![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 11
2022
Wang, Katharina 
ORCID: https://orcid.org/0000-0002-7795-1395; Schütze, Ina; Gulde, Sebastian; Bechmann, Nicole ORCID: https://orcid.org/0000-0002-6932-333X; Richter, Susan ORCID: https://orcid.org/0000-0002-3549-2477; Helm, Jana; Lauseker, Michael; Maurer, Julian; Reul, Astrid; Spoettl, Gerald; Klink, Barbara; William, Doreen; Knösel, Thomas; Friemel, Juliane; Bihl, Michel ORCID: https://orcid.org/0000-0002-5884-739X; Weber, Achim; Fankhauser, Maria; Schober, Laura; Vetter, Diana; Broglie Däppen, Martina; Ziegler, Christian G ORCID: https://orcid.org/0000-0002-4345-696X; Ullrich, Martin ORCID: https://orcid.org/0000-0001-6104-6676; Pietzsch, Jens; Bornstein, Stefan R; Lottspeich, Christian; Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161; Fassnacht, Martin; Wenter, Vera Ursula Julia ORCID: https://orcid.org/0000-0001-7385-5702; Ladurner, Roland; Hantel, Constanze; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875; Eisenhofer, Graeme; Grossman, Ashley B; Pacak, Karel ORCID: https://orcid.org/0000-0002-3541-3767; Beuschlein, Felix ORCID: https://orcid.org/0000-0001-7826-3984; Auernhammer, Christoph J; Pellegata, Natalia S und Nölting, Svenja ORCID: https://orcid.org/0000-0002-7064-590X
(2022):
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
In: Endocrine-Related Cancer, Bd. 29, Nr. 6: S. 285-306
ORCID: https://orcid.org/0000-0002-7795-1395; Schütze, Ina; Gulde, Sebastian; Bechmann, Nicole ORCID: https://orcid.org/0000-0002-6932-333X; Richter, Susan ORCID: https://orcid.org/0000-0002-3549-2477; Helm, Jana; Lauseker, Michael; Maurer, Julian; Reul, Astrid; Spoettl, Gerald; Klink, Barbara; William, Doreen; Knösel, Thomas; Friemel, Juliane; Bihl, Michel ORCID: https://orcid.org/0000-0002-5884-739X; Weber, Achim; Fankhauser, Maria; Schober, Laura; Vetter, Diana; Broglie Däppen, Martina; Ziegler, Christian G ORCID: https://orcid.org/0000-0002-4345-696X; Ullrich, Martin ORCID: https://orcid.org/0000-0001-6104-6676; Pietzsch, Jens; Bornstein, Stefan R; Lottspeich, Christian; Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161; Fassnacht, Martin; Wenter, Vera Ursula Julia ORCID: https://orcid.org/0000-0001-7385-5702; Ladurner, Roland; Hantel, Constanze; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875; Eisenhofer, Graeme; Grossman, Ashley B; Pacak, Karel ORCID: https://orcid.org/0000-0002-3541-3767; Beuschlein, Felix ORCID: https://orcid.org/0000-0001-7826-3984; Auernhammer, Christoph J; Pellegata, Natalia S und Nölting, Svenja ORCID: https://orcid.org/0000-0002-7064-590X
(2022):
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
In: Endocrine-Related Cancer, Bd. 29, Nr. 6: S. 285-306
Warde, Kate M.; Lim, Yi Jan; Ribes Martinez, Eduardo; Beuschlein, Felix; O'Shea, Paula; Hantel, Constanze und Dennedy, Michael Conall
(2022):
Mitotane Targets Lipid Droplets to Induce Lipolysis in Adrenocortical Carcinoma.
In: Endocrinology, Bd. 163, Nr. 9, bqac102
Bornstein, Stefan; Shapiro, Igor; Malyukov, Maria; Zuellig, Richard; Luca, Edlira; Gelfgat, Evgeny; Beuschlein, Felix; Noelting, Svenja; Berruti, Alfredo; Sigala, Sandra; Peitzsch, Mirko; Steenblock, Charlotte; Ludwig, Barbara; Kugelmeier, Patrick und Hantel, Constanze
(2022):
Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin.
In: Cell Death & Disease, Bd. 13, Nr. 7, 648
2019
Siebert, Claudia; Ciato, Denis; Murakami, Masanori; Frei-Stuber, Ludwig; Perez-Rivas, Luis Gustavo; Monteserin-Garcia, Jose Luis; Noelting, Svenja; Maurer, Julian; Feuchtinger, Annette; Walch, Axel K.; Haak, Harm R.; Bertherat, Jerome; Mannelli, Massimo; Fassnacht, Martin; Korpershoek, Esther; Reincke, Martin; Stalla, Gnter K.; Hantel, Constanze und Beuschlein, Felix
(19. Juli 2019):
Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma.
In: Frontiers in Endocrinology, Bd. 10, 487
[PDF, 4MB]
2017
Hasanovic, Anida; Ruggiero, Carmen; Volante, Marco; Hantel, Constanze; Lalli, Enzo und Mus-Veteau, Isabelle
(2017):
Patched drug efflux inhibitors enhances chemotherapy efficiency in vitro and in vivo.
In: International Journal of Molecular Medicine, Bd. 40:
S36-S36
2016
Jung, Sara; Nagy, Zoltan; Fassnacht, Martin; Zambetti, Gerard; Weiss, Max; Reincke, Martin; Igaz, Peter; Beuschlein, Felix und Hantel, Constanze
(2016):
Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma.
In: Endocrine-Related Cancer, Bd. 23, Nr. 10: S. 825-837
Hantel, Constanze und Beuschlein, Felix
(2016):
Xenograft models for adrenocortical carcinoma.
In: Molecular and Cellular Endocrinology, Bd. 421, Nr. C: S. 28-33
Hantel, Constanze; Ozimek, Alexandra; Lira, Regia; Ragazzon, Bruno; Jäckel, Carsten; Frantsev, Roman; Reincke, Martin; Bertherat, Jérôme; Mussack, Thomas und Beuschlein, Felix
(2016):
TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors.
In: Molecular and Cellular Endocrinology, Bd. 423, Nr. C: S. 87-95
Beuschlein, Felix; Jakoby, Judith; Mentz, Susanne; Zambetti, Gerard; Jung, Sara; Reincke, Martin; Süss, Regine und Hantel, Constanze
(2016):
IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma.
In: Molecular and Cellular Endocrinology, Bd. 428, Nr. C: S. 82-88
Hantel, Constanze; Shapiro, Igor; Poli, Giada; Chiapponi, Costanza; Bidlingmaier, Martin; Reincke, Martin; Luconi, Michaela; Jung, Sara und Beuschlein, Felix
(2016):
Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation.
In: Oncotarget, Bd. 7, Nr. 48: S. 79278-79290
2013
Gaujoux, Sébastien; Hantel, Constanze; Launay, Pierre; Bonnet, Stéphane; Perlemoine, Karine; Lefèvre, Lucile; Guillaud-Bataille, Marine; Beuschlein, Felix; Tissier, Frédérique; Bertherat, Jérôme; Rizk-Rabin, Marthe und Ragazzon, Bruno
(2013):
Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R.
In: PLOS ONE 8(2), e55743 [PDF, 2MB]
In: PLOS ONE 8(2), e55743 [PDF, 2MB]